ALLMedicine™ Postpartum Hemorrhage Center
Research & Reviews 1,360 results
https://doi.org/10.1007/s00404-022-06591-4 10.3109/14767058.2014.937698 10.1186/s12884-016-1217-0 10.1186/1471-2393-9-55 10.1097/jnr.0000000000000245 10.1097/GRF.0b013e3181cc406d 10.1097/01.SMJ.0000152760.34443.86 10.1111/ajo.13099 10.1016/j.ajog.2013.07.007 10.1016/j.ejogrb.2019.05.022 10.1111/1471-0528.14523 10.1038/jp.2016.225 10.1097/01.aoa.0000397118.20085.45 10.1007/s00404-021-06374-3 10.1016/j.ajog.2013.10.872 10.1016/j.curobgyn.2005.10.002 10.2147/CLEP.S93675 10.1080/14767058.2017.1394288 10.1111/j.1600-0412.2011.01107.x 10.5694/j.1326-5377.2007.tb01308.x 10.1097/00006254-200203000-00004
Archives of Gynecology and Obstetrics; Thams AB, Larsen MH et. al.
May 21st, 2022 - To assess incidence and risk factors for postpartum hemorrhage (PPH) and identify women at high risk of recurrence in the subsequent pregnancy. This register-based study includes data on women from the Capital Region of Denmark with two consecutiv...
https://doi.org/10.1016/j.jogc.2021.01.016
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Campos CI, Kujundzic W et. al.
May 20th, 2022 - Diffuse Uterine Arteriovenous Malformations as an Unusual Cause of Secondary Postpartum Hemorrhage.|2022|Campos CI,Kujundzic W,Vergara-Galliadi LM,Ávila F,Nieto-Calvache AJ,|
https://doi.org/10.1016/j.placenta.2022.05.004
Placenta Takahashi H, Tanaka H et. al.
May 18th, 2022 - To clarify the perinatal outcome of retained products of conception (RPOC) after 22 weeks or more. The retrospective cohort study reviewed medical records of patients with RPOC without placenta previa at 186 Japanese perinatal centers. Of the 323 ...
https://clinicaltrials.gov/ct2/show/NCT05376410
May 17th, 2022 - Placenta accreta, which was a rare diagnosis before, is now one of the most important causes of postpartum hemorrhage and hysterectomy. Trigger receptor expressed on myeloid cells (TREM), interacts with Toll-like receptors (TLRs) that play an impo...
https://doi.org/10.1016/j.jogc.2022.03.017
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Kazi S, Arusi I et. al.
May 16th, 2022 - Higher rates of postpartum hemorrhage (PPH) have been reported for women with von Willebrand disease (VWD). Comprehensive multidisciplinary care reduces these rates; thus PPH may not be secondary to VWD. We conducted a retrospective review for the...
Guidelines 9 results
https://doi.org/10.1016/j.jacr.2020.09.011
Journal of the American College of Radiology : JACR; , Uyeda JW et. al.
Nov 7th, 2020 - Postpartum hemorrhage (PPH) can be categorized as primary or early if occurring in the first 24 hours after delivery, whereas late or delayed PPH occurs between 24 hours and 6 weeks. Most of the causes of PPH can be diagnosed clinically, but imagi...
https://doi.org/10.1097/AOG.0000000000003565
Obstetrics and Gynecology;
Nov 26th, 2019 - Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54-93% of maternal deaths due to obstetric hemorrhage may be preventable. Studie...
https://doi.org/10.1097/AOG.0000000000003564
Obstetrics and Gynecology;
Nov 26th, 2019 - Postpartum hemorrhage causes approximately 11% of maternal deaths in the United States and is the leading cause of death that occurs on the day of birth. Importantly, 54-93% of maternal deaths due to obstetric hemorrhage may be preventable. Studie...
https://doi.org/10.1097/AOG.0000000000002346
Obstetrics and Gynecology;
Sep 25th, 2017 - Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality wor...
https://doi.org/10.1016/j.ejogrb.2015.12.012
European Journal of Obstetrics, Gynecology, and Reproduct... Sentilhes L, Vayssière C et. al.
Jan 17th, 2016 - Postpartum haemorrhage (PPH) is defined as blood loss ≥500mL after delivery and severe PPH as blood loss ≥1000mL, regardless of the route of delivery (professional consensus). The preventive administration of uterotonic agents just after delivery ...
Drugs 14 results see all →
Clinicaltrials.gov 98 results
https://clinicaltrials.gov/ct2/show/NCT05376410
May 17th, 2022 - Placenta accreta, which was a rare diagnosis before, is now one of the most important causes of postpartum hemorrhage and hysterectomy. Trigger receptor expressed on myeloid cells (TREM), interacts with Toll-like receptors (TLRs) that play an impo...
https://clinicaltrials.gov/ct2/show/NCT05352256
Apr 28th, 2022 - Rationale and background: Given the limitations of animal reproductive studies, pre-approval clinical trials in human populations, and post-marketing spontaneous adverse event reports to produce evidence on the safety of medical products and vacci...
https://clinicaltrials.gov/ct2/show/NCT04502173
Apr 22nd, 2022 - The purpose of this implementation research study is to generate evidence that informs the successful uptake and adoption of the Ellavi UBT within Kenyan MOH PPH management programs for both public and private sector programs. The investigators ai...
https://clinicaltrials.gov/ct2/show/NCT05236985
Apr 22nd, 2022 - Oxytocin is the most commonly used uterotonic agent worldwide to achieve adequate uterine tone and prevent postpartum hemorrhage. Over the past decade, the trend has been towards lowering the dose to reduce oxytocin-related adverse effects includi...
https://clinicaltrials.gov/ct2/show/NCT05232981
Apr 20th, 2022 - This randomized control trial will be conducted at Tanta University hospital, Egypt, from 2022 to 2024. Tanta University Hospital is considered the main tertiary hospital at the center of Nile Delta . Cases, suspected to have PAS, are recruited fr...
News 135 results
https://www.medscape.com/viewarticle/972779
Apr 26th, 2022 - Multifetal pregnancy reduction (MPR) was developed in the 1980s in the wake of significant increases in the incidence of triplets and other higher-order multiples emanating from assisted reproductive technologies (ART). It was offered to reduce fe...
https://www.medscape.com/viewarticle/969123
Feb 24th, 2022 - Use of neuraxial analgesia for vaginal delivery is associated with a 14% decreased risk for severe maternal morbidity, in part from a reduction in postpartum hemorrhage, new research shows. The findings indicate that increasing the use of epidural...
https://www.medscape.com/viewarticle/968877
Feb 19th, 2022 - Members of the LGBTQ community who give birth appear to have a greater risk of hypertensive disorders of pregnancy and postpartum hemorrhage, according to new research presented at the annual meeting sponsored by the Society for Maternal-Fetal Med...
https://www.mdedge.com/obgyn/article/251564/transgender-health/lgbtq-parents-fare-worse-giving-birth
Tara Haelle
Feb 8th, 2022 - Members of the LGBTQ community who give birth appear to have a greater risk of hypertensive disorders of pregnancy and postpartum hemorrhage, according to new research presented at the annual meeting sponsored by the Society for Maternal-Fetal Med.
https://www.medscape.com/viewarticle/967629
Feb 4th, 2022 - Methylergonovine is often used to control severe bleeding immediately after cesarean deliveries. But a new study suggests that the ergot alkaloid agent could benefit these women if administered before delivery, researchers from the University of I...